11.47
price down icon2.05%   -0.24
after-market After Hours: 11.30 -0.17 -1.48%
loading
10 X Genomics Inc stock is traded at $11.47, with a volume of 3.17M. It is down -2.05% in the last 24 hours and down -8.90% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$11.71
Open:
$11.82
24h Volume:
3.17M
Relative Volume:
1.14
Market Cap:
$1.31B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-5.6782
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-10.04%
1M Performance:
-8.90%
6M Performance:
+48.96%
1Y Performance:
-26.80%
1-Day Range:
Value
$11.18
$11.91
1-Week Range:
Value
$11.18
$13.22
52-Week Range:
Value
$6.78
$18.21

10 X Genomics Inc Stock (TXG) Company Profile

Name
Name
10 X Genomics Inc
Name
Phone
(925) 401-7300
Name
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Employee
1,306
Name
Twitter
@10xgenomics
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
TXG's Discussions on Twitter

Compare TXG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
TXG
10 X Genomics Inc
11.47 1.46B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
286.59 48.92B 2.97B 809.93M 1.33B 4.8743
Health Information Services icon
TEM
Tempus Ai Inc
96.39 17.25B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
65.61 13.59B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
90.52 7.99B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
35.70 7.14B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-11-25 Initiated Piper Sandler Neutral
Feb-13-25 Downgrade Leerink Partners Outperform → Market Perform
Sep-03-24 Initiated Leerink Partners Outperform
Jul-22-24 Upgrade Jefferies Hold → Buy
Jul-18-24 Downgrade JP Morgan Overweight → Neutral
Jul-10-24 Downgrade Deutsche Bank Buy → Hold
Jun-27-24 Downgrade Wolfe Research Outperform → Peer Perform
Jun-25-24 Downgrade Guggenheim Buy → Neutral
Jun-03-24 Resumed Jefferies Hold
May-01-24 Downgrade TD Cowen Buy → Hold
Dec-14-23 Initiated Guggenheim Buy
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Upgrade BofA Securities Underperform → Neutral
Jul-05-23 Resumed JP Morgan Overweight
May-10-23 Initiated Barclays Overweight
Mar-31-23 Initiated Stephens Overweight
Feb-02-23 Initiated UBS Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Aug-18-22 Downgrade Goldman Neutral → Sell
Jul-25-22 Initiated Canaccord Genuity Buy
Jul-15-22 Downgrade BofA Securities Neutral → Underperform
Jul-15-22 Downgrade William Blair Outperform → Mkt Perform
Oct-15-21 Resumed Cowen Outperform
Sep-14-21 Downgrade BofA Securities Buy → Neutral
Mar-15-21 Initiated William Blair Outperform
Dec-02-20 Initiated Goldman Neutral
Sep-09-20 Initiated Morgan Stanley Overweight
Jul-10-20 Initiated Stifel Buy
Mar-05-20 Initiated Guggenheim Buy
Jan-07-20 Initiated Citigroup Buy
Oct-07-19 Initiated BofA/Merrill Buy
Oct-07-19 Initiated Cowen Outperform
Oct-07-19 Initiated JP Morgan Overweight
Sep-24-19 Initiated Evercore ISI Outperform
View All

10 X Genomics Inc Stock (TXG) Latest News

pulisher
Oct 10, 2025

Trifecta Capital Advisors LLC Makes New $338,000 Investment in 10x Genomics $TXG - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 - BioSpace

Oct 09, 2025
pulisher
Oct 09, 2025

Q3 Results Nov 6: 10x Genomics to Report Financial Results, Webcast and Call to Discuss Outlook - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Can 10x Genomics Inc. stock deliver surprise earnings beatWeekly Profit Summary & Safe Entry Trade Reports - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

10X Genomics Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo

Oct 08, 2025
pulisher
Oct 08, 2025

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

10X Genomics Hits Day Low of $11.54 Amid Price Pressure - Markets Mojo

Oct 08, 2025
pulisher
Oct 07, 2025

10x Genomics (NASDAQ:TXG) Trading Down 7.6%What's Next? - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Why 10x Genomics Inc. (1KJ) stock stays on top picksWall Street Watch & Safe Capital Growth Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is 10x Genomics Inc. (1KJ) stock bottoming after sell offRecession Risk & Low Drawdown Investment Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to use a screener to detect 10x Genomics Inc. breakoutsTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Public Employees Retirement System of Ohio Raises Position in 10x Genomics $TXG - MarketBeat

Oct 05, 2025
pulisher
Oct 04, 2025

10x Genomics (NASDAQ:TXG) Upgraded to "Buy" at Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

61,470 Shares in 10x Genomics $TXG Purchased by Lecap Asset Management Ltd. - MarketBeat

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about 10x Genomics Inc stockInstitutional Holding Changes & Small Investment Trading Plans - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

4 Best Genetic Sequencing Stocks To Buy in 2025 - The Motley Fool

Oct 02, 2025
pulisher
Oct 02, 2025

Wealth Enhancement Advisory Services LLC Increases Stock Holdings in 10x Genomics $TXG - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Pattern recognition hints at 10x Genomics Inc. upside2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

10x Genomics Aims For Growth Despite Funding Uncertainty - Finimize

Oct 01, 2025
pulisher
Sep 30, 2025

Is 10x Genomics Inc. a candidate for recovery play2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why 10x Genomics Inc. (1KJ) stock is listed among top recommendationsExit Point & Intraday High Probability Setup Alerts - newser.com

Sep 30, 2025
pulisher
Sep 28, 2025

10x Genomics Inc 1KJ Stock Analysis and ForecastFundamental Stock Analysis & Small Investment Growth Tips - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What analysts say about 10x Genomics Inc 1KJ stockChart Pattern Recognition & Exceptional Capital Investment - Early Times

Sep 27, 2025
pulisher
Sep 24, 2025

10x Genomics (TXG): Is the Market Overlooking the Company's True Value? - simplywall.st

Sep 24, 2025
pulisher
Sep 23, 2025

78,249 Shares in 10x Genomics $TXG Purchased by Counterpoint Mutual Funds LLC - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Pallas Capital Advisors LLC Purchases 32,996 Shares of 10x Genomics $TXG - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

What institutional flow reveals about 10x Genomics Inc.Earnings Beat & Community Supported Trade Ideas - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Goldman Sachs Group Inc. Has $5.63 Million Holdings in 10x Genomics $TXG - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Risk Hedge: Does 10x Genomics Inc. offer margin of safety2025 Earnings Impact & Growth Focused Investment Plans - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Kera Capital Partners Inc. Buys Shares of 31,018 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Acadian Asset Management LLC Acquires 254,607 Shares of 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Investment Report: Does Future FinTech Group Inc have consistent dividend growthJuly 2025 Outlook & Precise Swing Trade Entry Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Insider Trends: Is 10x Genomics Inc. stock a good pick for beginners2025 Key Lessons & Risk Controlled Swing Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Layoff Watch: Can 10x Genomics Inc stock outperform in a bear market2025 Market Overview & Comprehensive Market Scan Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stock Position in 10x Genomics $TXG - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Breakouts Watch: Can 10x Genomics Inc. sustain earnings growth2025 Price Momentum & Verified High Yield Trade Plans - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Can 10x Genomics Inc be the next market leader2025 Momentum Check & Free High Return Stock Watch Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Risks Report: Will 10x Genomics Inc outperform its industry peersOil Prices & Smart Investment Allocation Tips - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Institution Moves: Can 10x Genomics Inc withstand a market correction2025 Historical Comparison & Stepwise Trade Execution Plans - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Short Squeeze: Will 10x Genomics Inc. benefit from rising consumer demandJuly 2025 Levels & AI Powered Market Trend Analysis - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Targets Report: What is the long term forecast for Malibu Boats Inc. stockPortfolio Return Summary & Advanced Technical Analysis Signals - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Momentum: Can 10x Genomics Inc outperform in the next rallyMarket Risk Report & Capital Efficiency Focused Strategies - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

10x Genomics (NASDAQ:TXG) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

New Highs: Is 10x Genomics Inc in a long term uptrend2025 Technical Patterns & Growth Focused Entry Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Breakout Zone: Is 10x Genomics Inc in a long term uptrendDollar Strength & Real-Time Stock Price Movement Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Amundi Has $2.55 Million Position in 10x Genomics $TXG - MarketBeat

Sep 17, 2025

10 X Genomics Inc Stock (TXG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

10 X Genomics Inc Stock (TXG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Taich Adam
Chief Financial Officer
Aug 22 '25
Sale
13.79
22,315
307,657
309,273
Hindson Benjamin J.
See Remarks
Aug 22 '25
Sale
13.79
7,486
103,209
440,888
$11.86
price down icon 8.35%
$27.78
price down icon 0.39%
$33.47
price up icon 1.76%
$24.08
price down icon 0.50%
$28.36
price down icon 1.36%
health_information_services WAY
$35.70
price down icon 4.62%
Cap:     |  Volume (24h):